Epoetin beta for the treatment of chemotherapy-induced anemia: an update

Epoetin beta belongs to the class of erythropoiesis-stimulating agents (ESAs) that are currently available to treat anemic patients receiving chemotherapy. Chemotherapy-induced anemia affects a high percentage of cancer patients and, due to its negative effects on disease outcome and the patient’s q...

Descripción completa

Detalles Bibliográficos
Autores principales: Galli, Luca, Ricci, Clara, Egan, Colin Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356683/
https://www.ncbi.nlm.nih.gov/pubmed/25784818
http://dx.doi.org/10.2147/OTT.S77497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356683/
https://www.ncbi.nlm.nih.gov/pubmed/25784818
http://dx.doi.org/10.2147/OTT.S77497

Ejemplares similares